Orwell

Orwell Health operates as a digital healthcare company in South Korea, concentrating on improving mental well-being by lowering the barriers to accessing care. The company was established in August 2021 by a group of entrepreneurs who were then on the verge of graduating from Seoul National University's medical school. The founding CEO, Seungju Hong, was motivated to start the company after witnessing during his medical training the critical need for mental health support outside of traditional hospital settings.

The firm's core offering is 'Inside,' a B2B mental care solution designed for corporate clients to provide to their employees. This platform aims to address the high rates of depression and suicide in South Korea by offering accessible and engaging mental health services. The business model is centered on providing this application to companies, which then offer it as a benefit to their workforce. The 'Inside' service includes features such as daily emotional recording, self-assessment tools, assistance in finding psychiatric professionals, and non-face-to-face counseling and coaching services.

Since its inception, Orwell Health has secured capital to fuel its growth. A seed investment was received from SpringCamp in December 2021. This was followed by a Pre-A series funding round in August 2022, where the company raised 2.6 billion KRW (approximately $1.99M USD). Investors in the company include KB Investment, We Ventures, Dodam Ventures, and Tail End Capital Partners, among others. This funding supports Orwell Health's mission to innovate within the mental health sector, moving care beyond the confines of a doctor's office.

Keywords: Orwell Health, Inside, mental healthcare, digital health, B2B mental care, employee wellness, South Korea, Seungju Hong, corporate mental health, mental health platform, digital therapy, self-assessment, emotional tracking, online counseling, Seoul National University, SpringCamp, KB Investment, We Ventures, Dodam Ventures, healthtech, preventative care